STOCKWATCH
·
Healthcare Research- Analytics & Technology
Quarterly Updates3 Nov 2025, 02:49 pm

Vimta Labs Reports Q2 & H1 FY26 Results: Highest Ever Quarterly Revenue at Rs. 1,045 Mn, 22.3% YoY Growth

AI Summary

Vimta Labs Limited, a leading Contract Research and Testing Organisation, has announced its financial results for the quarter and half year ended September 30, 2025. The company reported the highest ever quarterly revenue of Rs. 1,045 Mn, a 22.3% YoY growth. The EBITDA margins stood at 35.3% and the PAT margin was at 19.1%. The growth was driven by the pharmaceutical research and testing services and food testing services. The company also had a successful WHO audit for Clinical Research during the quarter.

Key Highlights

  • Highest ever quarterly revenue of Rs. 1,045 Mn
  • 22.3% YoY growth in total income
  • EBITDA margins at 35.3%
  • PAT margin at 19.1%
  • Successful WHO audit for Clinical Research
VIMTALABS
Healthcare Research- Analytics & Technology
VIMTA LABS LTD.-$

Price Impact